Rigel Pharmaceuticals (RIGL)
Nasdaq • RIGL • US7665597024
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 17.2% of free float sold short, 12.2 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
Market Cap
838m USD | # 5264 in US
Volume
259.42k shares | 12.19m USD
Shares Outstanding
18.83m
Free Float Shares
79.61% | 14.99m
